COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Isaac Newton Institute Seminar Series > Hyperbolicity of symmetric powers via Nevanlinna theory
Hyperbolicity of symmetric powers via Nevanlinna theoryAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact nobody. EMGW03 - Singularity theory and hyperbolicity The Green—Griffiths—Lang conjecture is regarded as a central problem in arithmetic geometry, as it relates the notion of complex hyperbolicity of a variety to its geometric properties and the distribution of its rational points. In particular, the case of m-th symmetric powers of varieties is related to the distribution of algebraic points of degree at most m. By using the theory of jet differentials, in 2022 Cadorel, Campana, and Rousseau gave geometric conditions to obtain pseudo-hyperbolicity of symmetric powers of varieties, which was applied, for instance, to obtain hyperbolicity for symmetric powers of generic hypersurfaces of high degree. In this talk, we will show a new technique coming from Nevanlinna theory that gives geometric criteria to obtain hyperbolicity of symmetric powers of varieties. Using this method, we provide concrete examples of varieties with hyperbolic symmetric powers. This is joint work with Hector Pasten. This talk is part of the Isaac Newton Institute Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsDevelopmental Biology Seminar Series Power and Vision Thinking Society: General and ParticularOther talksStructure formation and layering in two dimensional and dissipative drift wave turbulence GKM-Theory for cyclic quiver Grassmannians LMB Seminar: From regeneration to homeostasis: tissue-scale decision making The polymeric soul of proteins Richard Anslow on Impacts and Prebiotic Chemistry Hh signalling and the anti-tumour immune response: biology and new treatment opportunities |